COCRYSTAL PHARMA, INC. Cost of Goods Sold (Deprecated 2018-01-31)
COCRYSTAL PHARMA, INC. (COCP) reported Cost of Goods Sold (Deprecated 2018-01-31) of $977.16 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-18.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2013-11-18
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $977.16K, a 65.45% decline year-over-year.
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $1.40M, a 51.27% decline year-over-year.
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $1.44M, a 30.42% decline year-over-year.
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $2.27M, a 51.90% decline year-over-year.
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $9.97M, a 0.50% increase from fiscal 2011.
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $9.92M, a 17.70% increase from fiscal 2010.
- COCRYSTAL PHARMA, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2010 was $8.43M.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $977.16K 10-Q · filed 2013-11-18 | $2.38M derived: sum of 2 quarters · filed 2013-11-18 | $3.74M 10-Q · filed 2013-11-18 | $6.08M derived: sum of 4 quarters · filed 2013-11-18 | ||||
| 2013-06-30 | $1.40M 10-Q · filed 2013-08-15 | $2.84M 10-Q · filed 2013-08-15 | $5.11M derived: sum of 3 quarters · filed 2013-08-15 | $7.93M derived: sum of 4 quarters · filed 2013-11-18 | ||||
| 2013-03-31 | $1.44M 10-Q · filed 2013-05-10 | $3.70M derived: sum of 2 quarters · filed 2013-05-10 | $6.53M derived: sum of 3 quarters · filed 2013-11-18 | $9.41M derived: sum of 4 quarters · filed 2013-11-18 | ||||
| 2012-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $5.09M derived: sum of 2 quarters · filed 2013-11-18 | $7.97M derived: sum of 3 quarters · filed 2013-11-18 | $9.97M 10-K · filed 2013-04-01 | ||||
| 2012-09-30 | $2.83M 10-Q · filed 2013-11-18 | $2.87M 10-Q · filed 2012-11-14 | $5.71M derived: sum of 2 quarters · filed 2013-11-18 | $7.70M 10-Q · filed 2013-11-18 | $7.82M 10-Q · filed 2012-11-14 | $12.48M derived: sum of 4 quarters · filed 2013-11-18 | ||
| 2012-06-30 | $2.88M 10-Q · filed 2013-08-15 | $4.95M 10-Q · filed 2013-08-15 | $9.66M derived: sum of 3 quarters · filed 2013-08-15 | $11.50M derived: sum of 4 quarters · filed 2013-08-15 | ||||
| 2012-03-31 | $2.06M 10-Q · filed 2013-05-10 | $1.78M 10-Q · filed 2012-05-21 | $6.77M derived: sum of 2 quarters · filed 2013-05-10 | $8.62M derived: sum of 3 quarters · filed 2013-05-10 | $10.31M derived: sum of 4 quarters · filed 2013-05-10 | |||
| 2011-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $6.55M derived: sum of 2 quarters · filed 2013-04-01 | $8.24M derived: sum of 3 quarters · filed 2013-04-01 | $9.92M 10-K · filed 2013-04-01 | $8.64M 10-K · filed 2012-04-16 | |||
| 2011-09-30 | $1.85M 10-Q · filed 2012-11-14 | $2.14M 10-Q · filed 2011-11-21 | $3.53M derived: sum of 2 quarters · filed 2012-11-14 | $5.21M 10-Q · filed 2012-11-14 | $4.67M 10-Q · filed 2011-11-21 | $7.90M derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | $1.69M 10-Q/A · filed 2012-09-28 | $1.31M 10-Q/A · filed 2011-09-09 | $3.36M 10-Q/A · filed 2012-09-28 | $2.52M 10-Q/A · filed 2011-09-09 | $6.06M derived: sum of 3 quarters · filed 2012-10-02 | $8.46M derived: sum of 4 quarters · filed 2012-10-02 | ||
| 2011-03-31 | $1.50M 10-Q/A · filed 2012-10-02 | $1.11M 10-Q · filed 2012-05-21 | $4.37M derived: sum of 2 quarters · filed 2012-10-02 | $6.77M derived: sum of 3 quarters · filed 2012-10-02 | $8.27M derived: sum of 4 quarters · filed 2012-10-02 | |||
| 2010-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $5.27M derived: sum of 2 quarters · filed 2012-04-16 | $6.77M derived: sum of 3 quarters · filed 2012-04-16 | $8.43M 10-K · filed 2012-04-16 | ||||
| 2010-09-30 | $2.40M 10-Q · filed 2011-11-21 | $3.90M derived: sum of 2 quarters · filed 2011-11-21 | $5.56M 10-Q · filed 2011-11-21 | |||||
| 2010-06-30 | $1.50M 10-Q/A · filed 2011-09-09 | $3.16M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |